cadmium has been researched along with Myelodysplastic Syndromes in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Angel, CR; Bishop, MR; Iversen, PL; Mata, JE; Swanson, SA; Tarantolo, SR | 1 |
1 trial(s) available for cadmium and Myelodysplastic Syndromes
Article | Year |
---|---|
Evidence of enhanced iron excretion during systemic phosphorothioate oligodeoxynucleotide treatment.
Topics: Cadmium; Chelating Agents; Copper; Dose-Response Relationship, Drug; Erythrocyte Count; Humans; Infusions, Intravenous; Iron; Iron Chelating Agents; Leukemia, Myeloid, Acute; Male; Metabolic Clearance Rate; Middle Aged; Myelodysplastic Syndromes; Oligodeoxyribonucleotides, Antisense; RNA, Messenger; Spectrophotometry, Atomic; Thionucleotides; Tumor Suppressor Protein p53; Zinc | 2000 |